Background: The Human Papillomavirus (HPV) is generally recognized to be the direct cause of cervical cancer. The development of effective anti-HPV vaccines, included in the portfolio of recommended vaccinations for any given community, led to the consolidation in many countries of immunization programs to prevent HPV-related cervical cancers. In recent years, increasing evidence in epidemiology and molecular biology have supported the oncogenic role of HPV in the development of other neoplasm including condylomas and penile, anal, vulvar, vaginal, and oro-pharyngeal cancers. Men play a key role in the paradigm of HPV infection: both as patients and as part of the mechanisms of transmission. Data show they are affected almost as often as women. Moreover, no screening procedures for HPV-related disease prevention are applied in men, who fail to undergo routine medical testing by any medical specialist at all. They also do not benefit from government prevention strategies. Discussion: A panel of experts convened to focus on scientific, medical, and economic studies, and on the achievements from health organizations' intervention programs on the matter. One of the goals was to discuss on the critical issues emerging from the ongoing global implementation of HPV vaccination. A second goal was to identify contributions which could overcome the barriers that impede or delay effective vaccination programs whose purpose is to eradicate the HPV infection both in women and men. Summary: The reviewed studies on the natural history of HPV infection and related diseases in women and men, the increasing experience of HPV vaccination in women, the analysis of clinical effectiveness vs economic efficacy of HPV vaccination, are even more supportive of the economic sustainability of vaccination programs both in women and men. Those achievements address increasing and needed attention to the issue of social equity in healthcare for both genders.

Towards the eradication of HPV infection through universal specific vaccination / Piergiorgio, Crosignani; Stefani, A. D.; Fara, Gaetano; Isidori, Andrea; Lenzi, Andrea; Carlo, Liverani; Alberto, Lombardi; Francesco, Mennini; Giorgio, Palu'; Sergio, Pecorelli; Peracino, Andrea P.; Carlo, Signorelli; Gian, Zuccotti. - In: BMC PUBLIC HEALTH. - ISSN 1471-2458. - 13:1(2013), p. 642. [10.1186/1471-2458-13-642]

Towards the eradication of HPV infection through universal specific vaccination

Gaetano Fara;ISIDORI, Andrea;LENZI, Andrea;
2013

Abstract

Background: The Human Papillomavirus (HPV) is generally recognized to be the direct cause of cervical cancer. The development of effective anti-HPV vaccines, included in the portfolio of recommended vaccinations for any given community, led to the consolidation in many countries of immunization programs to prevent HPV-related cervical cancers. In recent years, increasing evidence in epidemiology and molecular biology have supported the oncogenic role of HPV in the development of other neoplasm including condylomas and penile, anal, vulvar, vaginal, and oro-pharyngeal cancers. Men play a key role in the paradigm of HPV infection: both as patients and as part of the mechanisms of transmission. Data show they are affected almost as often as women. Moreover, no screening procedures for HPV-related disease prevention are applied in men, who fail to undergo routine medical testing by any medical specialist at all. They also do not benefit from government prevention strategies. Discussion: A panel of experts convened to focus on scientific, medical, and economic studies, and on the achievements from health organizations' intervention programs on the matter. One of the goals was to discuss on the critical issues emerging from the ongoing global implementation of HPV vaccination. A second goal was to identify contributions which could overcome the barriers that impede or delay effective vaccination programs whose purpose is to eradicate the HPV infection both in women and men. Summary: The reviewed studies on the natural history of HPV infection and related diseases in women and men, the increasing experience of HPV vaccination in women, the analysis of clinical effectiveness vs economic efficacy of HPV vaccination, are even more supportive of the economic sustainability of vaccination programs both in women and men. Those achievements address increasing and needed attention to the issue of social equity in healthcare for both genders.
2013
administration /&/ dosage; adolescent; adult; anti-hpv vaccines; cervical cancer; condylomas; disease eradication; female; genital cancer; global health; hpv infection; humans; immunization programs; incremental cost-effectiveness ratio; male; methods; oro-pharyngeal cancer; papillomavirus infections; papillomavirus vaccines; prevention /&/ control; program evaluation; universal vaccination; vaccination programs; young adult
01 Pubblicazione su rivista::01a Articolo in rivista
Towards the eradication of HPV infection through universal specific vaccination / Piergiorgio, Crosignani; Stefani, A. D.; Fara, Gaetano; Isidori, Andrea; Lenzi, Andrea; Carlo, Liverani; Alberto, Lombardi; Francesco, Mennini; Giorgio, Palu'; Sergio, Pecorelli; Peracino, Andrea P.; Carlo, Signorelli; Gian, Zuccotti. - In: BMC PUBLIC HEALTH. - ISSN 1471-2458. - 13:1(2013), p. 642. [10.1186/1471-2458-13-642]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/661759
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 20
  • Scopus 48
  • ???jsp.display-item.citation.isi??? 39
social impact